$LFST
LifeStance Health Group, Inc.

2022 Q3 Form 10-Q Financial Statement

#000095017022016508 Filed on August 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2021 Q4
Revenue $217.6M $209.5M $190.0M
YoY Change 25.15% 30.51% 60.85%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $81.25M $103.6M $151.5M
YoY Change -50.14% 21.15% -51.32%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.680M $6.750M $15.36M
YoY Change 93.69% 119.87% 35.09%
% of Gross Profit
Operating Expenses $256.4M $270.0M $302.6M
YoY Change -14.11% 30.06% 165.07%
Operating Profit -$38.84M -$60.47M
YoY Change -68.85% 28.54%
Interest Expense $4.189M $7.133M -$3.602M
YoY Change 19.58% -69.22% -49.47%
% of Operating Profit
Other Income/Expense, Net -$3.367M -$7.332M -$1.171M
YoY Change -25.76% -72.62% 44.39%
Pretax Income -$42.21M -$67.80M -$118.6M
YoY Change -67.33% -8.15% 1578.76%
Income Tax -$4.353M $923.0K -$10.61M
% Of Pretax Income
Net Earnings -$37.85M -$68.73M -$108.0M
YoY Change -68.57% -1.86% 1868.12%
Net Earnings / Revenue -17.4% -32.8% -56.86%
Basic Earnings Per Share
Diluted Earnings Per Share -$105.9K -$194.3K -$312.0K
COMMON SHARES
Basic Shares Outstanding 376.2M 353.7K 374.1M
Diluted Shares Outstanding 357.5K 353.7K

Balance Sheet

Concept 2022 Q3 2022 Q2 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $90.34M $96.69M $148.0M
YoY Change -57.41% -64.99%
Cash & Equivalents $90.34M $96.69M $148.0M
Short-Term Investments
Other Short-Term Assets $48.97M $47.86M $4.342M
YoY Change 6.12% 72.13% 436.05%
Inventory
Prepaid Expenses
Receivables $113.3M $99.74M $76.08M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $252.6M $244.3M $266.5M
YoY Change -23.07% -32.9% 249.4%
LONG-TERM ASSETS
Property, Plant & Equipment $193.4M $190.7M $152.2M
YoY Change 68.1% 107.73% 156.52%
Goodwill $1.250B $1.244B $1.205B
YoY Change 7.74% 9.22% 9.64%
Intangibles $272.5M $282.1M $300.4M
YoY Change -11.53% -10.88% -9.75%
Long-Term Investments
YoY Change
Other Assets $11.42M $7.888M $3.448M
YoY Change 236.95% 139.03%
Total Long-Term Assets $1.727B $1.724B $1.661B
YoY Change 8.87% 11.22% 11.19%
TOTAL ASSETS
Total Short-Term Assets $252.6M $244.3M $266.5M
Total Long-Term Assets $1.727B $1.724B $1.661B
Total Assets $1.980B $1.969B $1.927B
YoY Change 3.39% 2.83% 22.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.947M $12.94M $14.15M
YoY Change 158.52% 29.96% 84.08%
Accrued Expenses $90.88M $87.42M $26.51M
YoY Change 5.75% -1.95% 80.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.145M $1.500M $1.323M
YoY Change 62.13% -7.35% -64.61%
Total Short-Term Liabilities $112.3M $111.5M $116.8M
YoY Change 6.72% -0.9% 53.78%
LONG-TERM LIABILITIES
Long-Term Debt $212.0M $203.4M $157.4M
YoY Change 34.68% 29.48% -56.58%
Other Long-Term Liabilities $66.96M $64.54M $50.33M
YoY Change 192.49% 310.97% 342.88%
Total Long-Term Liabilities $335.9M $325.8M $265.3M
YoY Change 26.9% 26.67% -42.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $112.3M $111.5M $116.8M
Total Long-Term Liabilities $335.9M $325.8M $265.3M
Total Liabilities $448.2M $437.4M $382.1M
YoY Change 21.16% 18.28% -28.84%
SHAREHOLDERS EQUITY
Retained Earnings -$526.0M -$488.1M -$357.1M
YoY Change 111.2% 279.6% 2620.55%
Common Stock $2.054B $2.019B $1.902B
YoY Change 14.52% 20.69% 130898.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.532B $1.531B $1.545B
YoY Change
Total Liabilities & Shareholders Equity $1.980B $1.969B $1.927B
YoY Change 3.39% 2.83% 22.77%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2021 Q4
OPERATING ACTIVITIES
Net Income -$37.85M -$68.73M -$108.0M
YoY Change -68.57% -1.86% 1868.12%
Depreciation, Depletion And Amortization $7.680M $6.750M $15.36M
YoY Change 93.69% 119.87% 35.09%
Cash From Operating Activities $5.730M $7.833M $30.63M
YoY Change -140.33% -146.31% 636.42%
INVESTING ACTIVITIES
Capital Expenditures -$15.10M -$25.87M -$38.68M
YoY Change -37.13% 24.82% 264.57%
Acquisitions
YoY Change
Other Investing Activities -$5.176M -$12.17M -$40.89M
YoY Change -73.56% -68.28% -69.5%
Cash From Investing Activities -$20.27M -$38.04M -$79.56M
YoY Change -53.49% -35.63% -44.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.192M 12.90M -15.17M
YoY Change -230.65% -95.87% -111.3%
NET CHANGE
Cash From Operating Activities 5.730M 7.833M 30.63M
Cash From Investing Activities -20.27M -38.04M -79.56M
Cash From Financing Activities 8.192M 12.90M -15.17M
Net Change In Cash -6.350M -17.30M -64.09M
YoY Change -90.09% -107.31% 927.31%
FREE CASH FLOW
Cash From Operating Activities $5.730M $7.833M $30.63M
Capital Expenditures -$15.10M -$25.87M -$38.68M
Free Cash Flow $20.83M $33.70M $69.31M
YoY Change 112.45% 785.16% 369.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
2739000
lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
11
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 6000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
3307000
dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
54281000
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85251
dei City Area Code
CityAreaCode
602
dei Local Phone Number
LocalPhoneNumber
767-2100
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
LFST
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
54281000
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
376181577
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96686000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
148029000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
99740000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
76078000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
47860000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
42413000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
244286000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
266520000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
190694000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
152242000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
282088000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
300355000
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
325836000
CY2022Q2 us-gaap Goodwill
Goodwill
1243721000
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
265329000
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2022Q2 us-gaap Liabilities
Liabilities
437376000
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1832801
dei Entity Address Address Line1
EntityAddressAddressLine1
4800 N. Scottsdale Road
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001845257
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40478
dei Entity Registrant Name
EntityRegistrantName
LifeStance Health Group, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50325000
CY2021Q4 us-gaap Goodwill
Goodwill
1204544000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7888000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3448000
CY2022Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
1724391000
CY2022Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
3653000
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1660589000
CY2022Q2 us-gaap Assets
Assets
1968677000
CY2021Q4 us-gaap Assets
Assets
1927109000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
12941000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14152000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
61215000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
60002000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
26209000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
26510000
CY2022Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
8984000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
14123000
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2191000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1965000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
111540000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
116752000
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
203364000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
157416000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
64538000
CY2021Q4 us-gaap Liabilities
Liabilities
382081000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
376181000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
376181000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
374255000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
374255000
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
3763000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
269999000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3743000
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2015665000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1898357000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-488127000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-357072000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
207594000
us-gaap Operating Expenses
OperatingExpenses
537945000
us-gaap Operating Expenses
OperatingExpenses
351607000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-60472000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1531301000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1545028000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1968677000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1927109000
CY2022Q2 us-gaap Revenues
Revenues
209527000
CY2021Q2 us-gaap Revenues
Revenues
160549000
us-gaap Revenues
Revenues
412622000
us-gaap Revenues
Revenues
303681000
CY2022Q2 us-gaap Other General Expense
OtherGeneralExpense
149697000
CY2021Q2 us-gaap Other General Expense
OtherGeneralExpense
109341000
us-gaap Other General Expense
OtherGeneralExpense
298590000
us-gaap Other General Expense
OtherGeneralExpense
208475000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
103559000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
85479000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
206928000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
118130000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
16743000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12774000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
32427000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
25002000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-47045000
us-gaap Operating Income Loss
OperatingIncomeLoss
-125323000
us-gaap Operating Income Loss
OperatingIncomeLoss
-47926000
CY2022Q2 lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
-180000
CY2021Q2 lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
-250000
lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
-614000
lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
-557000
CY2022Q2 lfst Transaction Costs
TransactionCosts
19000
CY2021Q2 lfst Transaction Costs
TransactionCosts
1996000
lfst Transaction Costs
TransactionCosts
297000
lfst Transaction Costs
TransactionCosts
3530000
CY2022Q2 us-gaap Interest Expense
InterestExpense
7133000
CY2021Q2 us-gaap Interest Expense
InterestExpense
23174000
us-gaap Interest Expense
InterestExpense
10574000
us-gaap Interest Expense
InterestExpense
31806000
CY2022Q2 us-gaap Other Expenses
OtherExpenses
0
CY2021Q2 us-gaap Other Expenses
OtherExpenses
1356000
us-gaap Other Expenses
OtherExpenses
0
us-gaap Other Expenses
OtherExpenses
1445000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7332000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-26776000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
954009000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-70033000
CY2021Q2 lfst Issuance Of Common Units For Acquisitions Of Businesses
IssuanceOfCommonUnitsForAcquisitionsOfBusinesses
1486000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11485000
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.37
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.37
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
353729
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-37338000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
313536
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-67804000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-73821000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-136808000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-85264000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
923000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
352297
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
309559
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1542518000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3788000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5753000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6549000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-68727000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-70033000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-131055000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-78715000
CY2022Q2 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
0
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-68727000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
57510000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1531301000
CY2021Q2 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
0
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
0
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
36750000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-68727000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-70033000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-131055000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-115465000
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.19
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.19
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.22
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.22
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.37
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.37
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
71750000
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
9000000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29515000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1544632000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1545028000
us-gaap Net Income Loss
NetIncomeLoss
-131055000
lfst Stock Issued During Period Value Restricted Stock Units Releases
StockIssuedDuringPeriodValueRestrictedStockUnitsReleases
-37000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-185000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
117550000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1531301000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
997836000
us-gaap Net Income Loss
NetIncomeLoss
-78715000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1000000
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
36750000
lfst Issuance Of Common Units For Acquisitions Of Businesses
IssuanceOfCommonUnitsForAcquisitionsOfBusinesses
1486000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
71750000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
9000000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30120000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1544632000
us-gaap Profit Loss
ProfitLoss
-131055000
us-gaap Profit Loss
ProfitLoss
-78715000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
32427000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
25002000
us-gaap Share Based Compensation
ShareBasedCompensation
117365000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
39126000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-88893000
us-gaap Share Based Compensation
ShareBasedCompensation
30120000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3380000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-70929000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5620000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
748000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1081000
lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
-614000
lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
-557000
lfst Endowment Of Shares
EndowmentOfShares
0
lfst Endowment Of Shares
EndowmentOfShares
9000000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
21900000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11831000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5351000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14964000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1731000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2261000
us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-289000
us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
9580000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
13471000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
15283000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11141000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7006000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
53775000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31803000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
35118000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
554169000
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
0
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
1000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
228000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
98800000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
7184000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2360000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
181230000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
310729000
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
1609000
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
11090000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
5587000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
478000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26409000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
335293000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-51343000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
257358000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
148029000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18829000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96686000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
276187000
us-gaap Interest Paid Net
InterestPaidNet
4927000
us-gaap Interest Paid Net
InterestPaidNet
24889000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
860000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
900000
lfst Unpaid Deferred Offering Costs Included In Accounts Payable And Other Accrued Expenses
UnpaidDeferredOfferingCostsIncludedInAccountsPayableAndOtherAccruedExpenses
0
lfst Unpaid Deferred Offering Costs Included In Accounts Payable And Other Accrued Expenses
UnpaidDeferredOfferingCostsIncludedInAccountsPayableAndOtherAccruedExpenses
5264000
lfst Equipment Financed Through Capital Leases
EquipmentFinancedThroughCapitalLeases
256000
lfst Equipment Financed Through Capital Leases
EquipmentFinancedThroughCapitalLeases
14000
lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
5683000
CY2021Q2 lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
10
lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
6
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12477000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5679000
lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
13055000
lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
10233000
lfst Issuance Of Common Units For Acquisitions Of Businesses
IssuanceOfCommonUnitsForAcquisitionsOfBusinesses
0
lfst Issuance Of Common Units For Acquisitions Of Businesses
IssuanceOfCommonUnitsForAcquisitionsOfBusinesses
1486000
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-01-28
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Use of Accounting Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires management to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2022Q2 lfst Acquisition Of Non Medical Assets
AcquisitionOfNonMedicalAssets
1
CY2022Q2 lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
4
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
14526000
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
430000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
2008000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
851000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
2048000
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
707000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
3515000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
1193000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
3799000
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
19000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
676000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
53000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
694000
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
166000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
221000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
230000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
227000
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
53000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
86000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
56000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
91000
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
901000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
2936000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
1683000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
3061000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
40170000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
39227000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
41287000
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
16802000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
49612000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
43293000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
51207000
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
989000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
5258000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
1685000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
5345000
CY2022Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
15813000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
44354000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
41608000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
45862000
CY2022Q2 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
901000
CY2021Q2 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
2936000
us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
1683000
us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
3061000
CY2022Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
740000
CY2022Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1211000
CY2022Q2 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
36091000
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
364350000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
82262000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
282088000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
362667000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
62312000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
300355000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9993000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9704000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
19950000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
19323000
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
222697000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
171768000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
32003000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19526000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
190694000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
152242000
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1500000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6750000
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3070000
CY2022Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
12637000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
17430000
CY2022Q2 lfst Financial Assets And Liabilities Fair Value Recurring
FinancialAssetsAndLiabilitiesFairValueRecurring
0
CY2021Q4 us-gaap Goodwill
Goodwill
1204544000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
39227000
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-50000
CY2022Q2 us-gaap Goodwill
Goodwill
1243721000
CY2020Q2 us-gaap Long Term Debt Maturities Repayment Terms
LongTermDebtMaturitiesRepaymentTerms
May 14, 2026
CY2022Q2 us-gaap Long Term Debt Maturities Repayment Terms
LongTermDebtMaturitiesRepaymentTerms
May 16, 2028
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
211000000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
161230000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1323000
CY2022Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6136000
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2491000
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
203364000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
157416000
CY2022Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1025000
CY2022Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1036000
CY2022Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
144000
CY2022Q2 us-gaap Interest Expense
InterestExpense
7133000
CY2021Q2 us-gaap Interest Expense
InterestExpense
23174000
us-gaap Interest Expense
InterestExpense
10574000
us-gaap Interest Expense
InterestExpense
31806000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
500000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
2000000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
2000000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
2000000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
2000000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive
202500000
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
211000000
CY2022Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
192304000
CY2021Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
186497
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
209527000
CY2022Q2 lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
160549000
CY2021Q2 lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
412622000
lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
303681000
lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
923000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3788000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5753000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6549000
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.014
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.051
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.042
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.077
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
239000
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
193529
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y7M6D
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
lfst Fair Value Of Mezzanine Equity
FairValueOfMezzanineEquity
36750000
lfst Number Of Office Facilities
NumberOfOfficeFacilities
19
lfst Lease Expiration Year
LeaseExpirationYear
2030
CY2021Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
7526000
CY2022Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
391000
CY2021Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
661000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
778000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1197000
CY2022Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
257000
CY2022Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
4413000
CY2021Q2 lfst Related Party Management Fees
RelatedPartyManagementFees
1356000
lfst Related Party Management Fees
RelatedPartyManagementFees
1445000
CY2021Q2 us-gaap Management Fee Expense
ManagementFeeExpense
0
CY2022Q2 lfst Related Party Fees
RelatedPartyFees
4375000
lfst Related Party Fees
RelatedPartyFees
4375000
CY2021Q4 lfst Business Combination Contingent Consideration
BusinessCombinationContingentConsideration
17430000
CY2020Q4 lfst Business Combination Contingent Consideration
BusinessCombinationContingentConsideration
16414000
lfst Business Combination Additions Related To Acquisitions
BusinessCombinationAdditionsRelatedToAcquisitions
5683000
CY2021 lfst Business Combination Additions Related To Acquisitions
BusinessCombinationAdditionsRelatedToAcquisitions
10685000
lfst Business Combination Payments Of Contingent Consideration
BusinessCombinationPaymentsOfContingentConsideration
-11090000
CY2021 lfst Business Combination Payments Of Contingent Consideration
BusinessCombinationPaymentsOfContingentConsideration
-12279000
lfst Business Combination Loss On Remeasurement
BusinessCombinationLossOnRemeasurement
614000
CY2021 lfst Business Combination Loss On Remeasurement
BusinessCombinationLossOnRemeasurement
2610000
CY2022Q2 lfst Business Combination Contingent Consideration
BusinessCombinationContingentConsideration
12637000
CY2021Q4 lfst Business Combination Contingent Consideration
BusinessCombinationContingentConsideration
17430000
lfst Operating Lease Expiration Year
OperatingLeaseExpirationYear
2032
CY2022Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
12137000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
23296000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
14104000
us-gaap Malpractice Insurance Coverage Floor
MalpracticeInsuranceCoverageFloor
3000000
us-gaap Malpractice Insurance Annual Coverage Limit
MalpracticeInsuranceAnnualCoverageLimit
8000000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-68727000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-70033000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-131055000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-115465000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
353729
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
313536
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
352297
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
309559
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.19
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.19
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.22
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.22
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.37
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.37
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.37
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.37
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34075
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
36894

Files In Submission

Name View Source Status
0000950170-22-016508-index-headers.html Edgar Link pending
0000950170-22-016508-index.html Edgar Link pending
0000950170-22-016508.txt Edgar Link pending
0000950170-22-016508-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lfst-20220630.htm Edgar Link pending
lfst-20220630.xsd Edgar Link pending
lfst-ex10_1.htm Edgar Link pending
lfst-ex10_2.htm Edgar Link pending
lfst-ex10_3.htm Edgar Link pending
lfst-ex10_4.htm Edgar Link pending
lfst-ex10_5.htm Edgar Link pending
lfst-ex10_6.htm Edgar Link pending
lfst-ex31_1.htm Edgar Link pending
lfst-ex31_2.htm Edgar Link pending
lfst-ex32_1.htm Edgar Link pending
lfst-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
lfst-20220630_lab.xml Edgar Link unprocessable
lfst-20220630_cal.xml Edgar Link unprocessable
lfst-20220630_def.xml Edgar Link unprocessable
lfst-20220630_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lfst-20220630_pre.xml Edgar Link unprocessable